INDEPENDENT. INTERNATIONAL. LEADERS.
The Research Management Committee (RMC) is made up of independent members whose primary role is to evaluate research proposals and actively help BioCanRx monitor the progress of its projects. The RMC will build and maintain a robust, competitive research portfolio founded on scientific excellence and network goals. All RMC funding and budget recommendations go to the Board of Directors for approval.
In order to avoid potential conflicts of interest, the voting RMC is composed of independent and primarily international experts in biotherapeutics.
Membership
 |
 |
 |
 |
| Dr. Stephen Russell Professor, Molecular Medicine Consultant, Hematology Mayo Clinic (USA) |
Dr. Bruce Seet Director, Medical Affairs, Sanofi-Pasteur (Canada) |
Dr. Grant McFadden Director, Center for Immunotherapy, Vaccines, and Virotherapy Biodesign Institute, Arizona State U, Tempe, AZ (USA) |
Dr. Len Seymour Founder and Chief Scientific Officer, Oxford Genetics (UK) |
 |
 |
 |
 |
| Dr. Alan Melcher Professor of Translational Immunotherapy, The Institute of Cancer Research, Chester Beatty Laboratories, London (UK) |
Dr. Ira Mellman Vice-President, Cancer Immunology, Genentech (USA) |
Dr. Cliona Rooney Professor, Baylor College of Medicine (USA) |
Dr. Chris Klebanoff Assistant Clinical Investigator, NCI Surgery Branch, NIH (USA) |
 |
 |
 |
 |
| Dr. Robert Coffin Entrepreneur & Founder, BioVex (USA) |
Dr. Steven Xanthoudakis Director, Licensing and External Research, Merck Research Laboratories (Canada) |
Dr. Jeffrey Hoch Professor, Department of Public Health Sciences, UC Davis |
Dr. Nicole Onetto Former Deputy Director and Chief Scientific Officer, Ontario Institute for Cancer Research (Canada) |
 |
|||
| Dr. Kelvin Chan Associate Scientist, Sunnybrook Health Sciences Centre (Canada) |
EX-OFFICIO MEMBERS (NON-VOTING)
Dr. John Bell
BioCanRx Scientific Director
Senior Scientist, the Ottawa Hospital Research Institute
Professor, uOttawa
Dr. Brian Lichty
BioCanRx Theme Leader
Associate Professor, Pathology and Molecular Medicine, McMaster University
Dr. Jason Moffat
BioCanRx Theme Leader
Associate Professor, Canada Research Chair in Functional Genomics of Cancer, University of Toronto
Dr. Brad Nelson
BioCanRx Theme Leader
Director and Distinguished Scientist, Deeley Research Centre, BCCA
Professor, Biochemistry and Microbiology, University of Victoria
Dr. Claude Perreault
Principal Investigator, IRIC
Professor, Faulty of Medicine, Université de Montréal
Hematologist, Maisonneuve-Rosemont Hospital
OBSERVERS
Dr. Stéphanie Michaud
President and CEO, BioCanRx
Dr. Kelley Parato
Director, Scientific Affairs, BioCanRx
Dr. Carmen Gervais
Deputy Director, Networks of Centres of Excellence
